Towa Pharmaceutical Competitors and Similar CompaniesClear all

Towa Pharmaceutical's competitors and similar companies include Quantum Pharmaceutical, AOP Orphan Pharmaceuticals, Zhejiang Jiuzhou Pharmaceutical and Grupo Menarini.

	Towa Pharmaceutical Towa Pharmaceutical (東和薬品株式会社) is a company that manufactures and suppliers of ethical drugs.	Quantum Pharmaceutical Quantum Pharmaceutical is a manufacturer and supplier of unlicensed medicines and hard-to-source products.	AOP Orphan Pharmaceuticals AOP Orphan is a company focused on clinical development, marketing and distribution of medicines for rare and complex diseases.	Zhejiang Jiuzhou Pharmaceutical Zhejiang Jiuzhou Pharmaceutical (浙江九洲药业股份有限公司) is a manufacturer and supplier of pharmaceutical products.	Grupo Menarini Grupo Menarini is a pharmaceutical company.
Founding Date	Founding Date 1951	Founding Date 2004	Founding Date 1996	Founding Date 1973	Founding Date 1961
Type	Type Public	Type Subsidiary	Type Private	Type Public	Type Private
Tags	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma
Locations	Locations HQ	Locations Hobson, GB HQ	Locations Wien, AT HQ Sofia, BG Meudon, FR Ismaning, DE Athina, GR Budapest, HU see more	Locations Taizhou, CN HQ	Locations Badalona, ES HQ
Employees	Employees N/A	Employees 4548% increase	Employees 5352% increase	Employees 5,001	Employees 5541% increase
Valuation ($)	Valuation ($) 992.5 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 1.9 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) ¥259.6b (FY, 2025)	Revenue (est.) £76.1m (FY, 2018)	Revenue (est.) N/A	Revenue (est.) ¥5.3b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods ¥144.8b (FY, 2025)	Cost of goods £54.5m (FY, 2018)	Cost of goods N/A	Cost of goods ¥3.5b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit ¥114.8b (FY, 2025)	Gross profit £21.6m (FY, 2018)	Gross profit N/A	Gross profit ¥2b (FY, 2025)	Gross profit N/A
Net income	Net income ¥19b (FY, 2025)	Net income (£8.3m) (FY, 2018)	Net income N/A	Net income ¥728.5m (FY, 2025)	Net income N/A